ESCALON MEDICAL CORP (ESMC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q4 '24: 3.5M Q1 '25: 2.8M Q2 '25: 3.2M Q3 '25: 3.5M Q4 '25: 2.6M Q1 '26: 2.7M Q2 '26: 3.6M Q3 '26: 2.6M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Gross Profit Quarterly

0 600K 1.2M 1.8M Q4 '24: 1.5M Q1 '25: 1.2M Q2 '25: 1.6M Q3 '25: 1.6M Q4 '25: 1.1M Q1 '26: 1.1M Q2 '26: 1.6M Q3 '26: 946.7K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-450K -300K -150K 0 150K 300K 450K Q4 '24: 138.3K Q1 '25: -27K Q2 '25: 255.9K Q3 '25: 276K Q4 '25: -371.8K Q1 '26: -202.8K Q2 '26: 98.7K Q3 '26: -419.3K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Net Income Quarterly

-900K 0 900K 1.8M 2.7M Q4 '24: 134.4K Q1 '25: -32.2K Q2 '25: 246K Q3 '25: 271.5K Q4 '25: -379.8K Q1 '26: -239.9K Q2 '26: 97.7K Q3 '26: 2.4M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q4 '24: 2M Q1 '25: 1.6M Q2 '25: 1.6M Q3 '25: 1.9M Q4 '25: 1.4M Q1 '26: 1.6M Q2 '26: 2M Q3 '26: 1.7M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Cash Flow Quarterly

-600K -400K -200K 0 200K 400K 600K Q4 '24: -339.9K Q1 '25: 33.3K Q2 '25: 300.9K Q3 '25: 30.7K Q4 '25: 15.8K Q1 '26: 85K Q2 '26: -517.4K Q3 '26: 281K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Free Cash Flow Quarterly

-600K -400K -200K 0 200K 400K 600K Q4 '24: -349.1K Q1 '25: 33.3K Q2 '25: 300.9K Q3 '25: 30.7K Q4 '25: 11.9K Q1 '26: 80.6K Q2 '26: -517.4K Q3 '26: 281K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q2 '24: 7.4M Q3 '24: 7.4M Q1 '25: 7.4M Q2 '25: 14.1M Q3 '25: 14.2M Q1 '26: 7.4M Q2 '26: 14.4M Q3 '26: 14.5M Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 0.00 0.04 0.08 0.12 Q4 '24: -0.02 Q1 '25: -0.03 Q2 '25: -0.00 Q3 '25: 0.04 Q4 '25: 0.00 Q1 '26: -0.02 Q2 '26: -0.03 Q3 '26: 0.11 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.